Cord Blood Uses for Grandparents

Umbilical cord blood, collected at birth, contains stem cells that can be stored for medical treatments. While it’s a natural match for the baby, it can also help family members like grandparents. This depends on HLA compatibility, which reduces transplant risks. Grandchildren often share partial matches with grandparents, making cord blood a possible option for treating conditions like leukemia, lymphoma, and certain immune disorders.

Key points:

• HLA Matching: Grandparents share at least one haplotype with grandchildren, allowing partial matches for cord blood transplants.
• FDA-Approved Uses: Includes treatments for blood cancers, anemia, and immune system issues.
• Experimental Research: Clinical trials are exploring cord blood’s role in treating strokes, Alzheimer’s, and Parkinson’s.
• Family Banking: Public vs private cord blood banking differs in availability, with private storage ensuring access for family use.

Stored cord blood offers multi-generational benefits, with flexible banking plans like Americord’s CryoMaxx™ making it accessible for families. Treatments are evolving, providing new possibilities for age-related conditions.

HLA Compatibility Between Grandchildren and Grandparents

What is HLA Matching?

Human Leukocyte Antigens (HLA) are proteins encoded by genes on chromosome 6 that help the immune system differentiate between the body’s own cells and foreign invaders.

In cord blood transplants, HLA compatibility is a key factor. A good match between the donor’s and recipient’s HLA genes reduces the risk of rejection and improves the chances of success. This is why doctors perform HLA typing, which involves comparing these genetic markers to find the best match.

"HLA compatibility is vital in cord blood transplantation, as it can significantly impact the procedure's success and reduce the risk of complications." - AlphaCord

Each person inherits 50% of their HLA markers from each parent. Because of this, family members are more likely to share HLA similarities than unrelated donors. There are 12 distinct HLA markers that doctors typically examine during the matching process, leading to millions of potential combinations. This genetic connection within families forms the basis for understanding compatibility between grandchildren and grandparents.

Match Rates for Grandparents

When thinking about HLA matching, it’s helpful to consider how the genetic overlap between grandchildren and grandparents translates into match rates. While a grandchild is less likely to match with a grandparent compared to a sibling, the connection is still valuable. Siblings have about a 25% chance of being a full match, but a grandchild will always share at least one haplotype with a biological grandparent. This makes them a partial or haploidentical match.

Here’s the advantage: cord blood transplants don’t need a perfect match. Unlike bone marrow transplants, which often require a 100% match (6 out of 6 HLA markers), cord blood can work effectively with just a 4 out of 6 match (67% match). This is because a newborn’s immune system is still developing, making their cells more adaptable.

"A major advantage of cord blood is that the immune system of a newborn baby is not yet fully developed. This means that the match that's required between the cord blood stem cells and the person receiving them is less strict." - Julie Grisham, Memorial Sloan Kettering Cancer Center

This flexibility is particularly beneficial for grandparents from diverse ethnic backgrounds. HLA types are closely tied to ancestry, and individuals from Asian, African, Hispanic, or Middle Eastern backgrounds often have more varied HLA types. This diversity can make finding a match in public registries more challenging, but partial matches from family sources like cord blood can offer a promising alternative.

FDA-Approved and Experimental Treatments Using Cord Blood

Current FDA-Approved Treatments

Cord blood has been approved by the FDA for hematopoietic stem cell transplants, which are used to treat over 80 conditions related to the blood and immune systems. Globally, more than 45,000 cord blood transplants have been performed to help regenerate these systems.

For grandparents, the most relevant treatments include blood cancers like leukemia and lymphoma. This is because cord blood contains hematopoietic progenitor cells (HPCs), which can rebuild a patient’s blood and immune system after chemotherapy or radiation. Other approved uses include treating bone marrow failure, certain types of anemia such as sickle cell disease, and immune system disorders.

These treatments require HLA compatibility testing between the grandchild’s cord blood and the grandparent to reduce the risk of graft-versus-host disease. While these therapies are well-established, researchers are pushing boundaries to explore new uses for cord blood in addressing age-related conditions.

Experimental Regenerative Applications

In addition to FDA-approved treatments, scientists are investigating how cord blood could benefit age-related health issues. Over 200 clinical trials have focused on cord tissue stem cells for conditions like Parkinson’s disease, heart disease, and Alzheimer’s. These studies explore both hematopoietic stem cells from cord blood and mesenchymal stromal cells (MSCs) derived from cord tissue.

Key research areas include stroke recovery, neurodegenerative diseases, and cardiovascular conditions. With stroke affecting many people in the U.S., the potential of cord blood in regenerative therapies is gaining attention.

Although these treatments are not yet FDA-approved, they point to exciting possibilities. Neonatal cells are often considered ideal for older patients because they are "new and unworn", potentially making them more effective than the patient’s own aging stem cells.

How to Use Stored Cord Blood for Grandparent Treatment

Eligibility Requirements

For a grandparent to receive treatment using stored cord blood, specific medical criteria must be met. One of the most critical factors is HLA compatibility, which helps reduce the risk of Graft-versus-Host Disease. This compatibility is determined through HLA typing, a process handled by the treating physician to ensure the stored cord blood is a safe match.

The grandparent must also have a qualifying medical condition. This could include an FDA-approved condition like leukemia, lymphoma, or sickle cell disease, or participation in an approved clinical trial. Additionally, the cord blood unit itself must meet quality standards, such as having a sufficient TNC (total nucleated cell) count and maintaining viability after thawing.

"Cord blood and cord tissue stem cells also hold the potential to benefit both immediate family members, such as parents and siblings, as well as second-degree family members, like aunts, uncles, and grandparents." - Americord Registry

The treating physician plays a key role in determining whether the stem cell count and HLA match are appropriate based on the grandparent's condition and physical size. It’s also important to confirm that the private bank’s contract allows for use by second-degree relatives, and that the facility is equipped to process cryopreserved stem cells properly.

Once eligibility is confirmed through medical evaluations and HLA typing, the next step is to follow a detailed release protocol to ensure the cord blood is safely prepared and delivered for the grandparent's treatment.

Release and Transportation Process

Once the grandparent is deemed eligible, the release process begins. The family or the treating physician must contact Americord Registry to initiate the procedure. This involves completing the necessary release forms and providing medical authorization. Americord's clinical team then works closely with the physician overseeing the grandparent's care to confirm medical requirements and determine how much cord blood is needed.

The cord blood unit is carefully retrieved from cryogenic storage, where it is preserved in vapor-phase liquid nitrogen at a temperature of -196° C. A specialized medical courier service is responsible for transporting the unit. This service ensures that the required temperature and chain of custody are maintained throughout the journey, preserving the sample's viability for treatment. This meticulous process guarantees the cord blood arrives in optimal condition, ready to support the grandparent's medical care.

Americord's Multi-Generational Banking Services

CryoMaxx™ Processing for Cell Preservation

Americord’s CryoMaxx™ processing method is designed to ensure maximum recovery and quality of stem cells during long-term storage. This method relies on manual processing for cord blood and minimal handling of perinatal tissues, which helps maintain the cells’ full potential for future medical applications. Before the samples are cryogenically frozen, they undergo thorough processing, HLA typing, and disease screening to meet strict quality standards. This meticulous approach ensures that even older family members, like grandparents, can benefit from highly viable cells when needed.

Stem cells are stored in specially designed 5-compartment vials, which allow for multiple treatments from a single sample. This storage method is particularly beneficial for multi-generational use, as it enables different family members to access portions of the stored cells at various times for different treatments.

"Americord's CryoMaxx™ processing method unlocks the full potential of umbilical cord blood and perinatal tissues... giving families more options for more treatments." - Americord Registry

Family Banking Plans

Americord offers family banking plans tailored to support multi-generational health care. The Advanced Family Plan, which includes both cord blood and tissue banking, is priced at $219/month for 24 months (totaling $5,269.15) with an additional $280 upfront collection and shipping fee. Families can also take advantage of 0% interest payment plans over 12 or 24 months, making the investment more budget-friendly. These flexible options align with the wide range of treatment possibilities available for families.

Conclusion

Cord blood banking is more than a one-time decision - it’s a long-term investment in your family’s health. While a grandchild’s cord blood is a perfect match for them, it also holds potential for HLA compatibility with grandparents. Beyond its use in established therapies, cord blood is being studied in hundreds of clinical trials for regenerative treatments targeting age-related conditions, offering promising medical options for the entire family.

What makes cord blood so valuable is its adaptability. Stored cord blood can support multiple treatments over time, thanks to advanced preservation techniques. As medical science evolves, therapies that are experimental today could become routine tomorrow. This makes banking cord blood a forward-thinking choice, ensuring access to treatments that may shape the future of healthcare.

Americord enhances this opportunity with its CryoMaxx™ processing technology and flexible payment plans starting at $219/month for 24 months. Their focus on quality and transparency ensures that your family’s biological resource remains viable for decades to come.

"As science continues to innovate in ways that will extend and enhance human life, we will always be at the forefront helping parents make the smartest choices to protect their families - so they can live longer, more fulfilling lives." - Americord Registry

For families with a history of treatable conditions - or for those who simply want to secure future health options - cord blood banking offers a sense of security that spans generations. The collection process is limited to birth, but the benefits can extend across a lifetime, making it a thoughtful and impactful choice for every family.

FAQs

Can my baby’s cord blood be used for a grandparent?

Yes, a grandparent may be able to use your baby’s cord blood if there’s sufficient HLA compatibility. This matching is essential for a successful transplant and to reduce the risk of complications. It’s important to consult a medical professional to evaluate the chances of a match and explore possible treatment options.

How do we check if a grandparent is an HLA match?

To find out if a grandparent is an HLA match, a tissue typing test is performed. This test examines the grandparent's human leukocyte antigens (HLA) and compares them with the recipient's to evaluate compatibility for a cord blood transplant.

What affects whether one cord blood unit is enough for an adult?

The suitability of a cord blood unit for an adult relies heavily on two factors: cell volume and HLA compatibility. For an individual weighing around 80 kg (176 lb), only about 8–12% of cord blood units contain an adequate cell volume. Additionally, ensuring proper compatibility is essential for a successful transplant.